The ovarian hyperstimulation syndrome: A self-made problem;Uberblick uber das ovarielle uberstimulations-syndrom: Ein reproduktionsmedizinisch-iatrogenes krankheitsbild mit internistischer konsequenz

Wiener Medizinische Wochenschrift

Volumn 147, Issue 22, 1997, Pages 516-524

  Ludwig, M ^a,b   Bauer, O ^a   Diedrich, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Ovarian hyperstimulation syndrome (OHSS); Pathophysiology; Prevention; Treatment

Indexed keywords

ALBUMIN; ANTIHISTAMINIC AGENT; CHORIONIC GONADOTROPIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GONADORELIN DERIVATIVE;

DEATH; FEMALE; HEMOCONCENTRATION; HUMAN; INFERTILITY THERAPY; OVARY HYPERSTIMULATION; PATHOPHYSIOLOGY; REVIEW; THROMBOEMBOLISM; DIFFERENTIAL DIAGNOSIS; FERTILIZATION IN VITRO; INTERNAL MEDICINE; PATIENT CARE; SUDDEN DEATH;

DEATH, SUDDEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FERTILIZATION IN VITRO; HUMANS; INTERNAL MEDICINE; OVARIAN HYPERSTIMULATION SYNDROME; PATIENT CARE TEAM; THROMBOEMBOLISM;

EID: 0031285376     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Aboulghar MA, Mansour RT, Serour GI, Amin Y: Ultrasonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 1990;53:933-935.
2. Aboulghar MA, Mansour RT, Serour GI, Riad R, Ramzi AM: Autotransfusion of the ascitic fluid in the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 1992;58:1056-1059.
3. Amso NN, Ahuja KK, Morris N, Shaw RW: Elective preembryo cryopreservation in ovarian hyperstimulation syndrome. J In Vitro Fert Embryo Transf 1989;6:312-314.
4. Amso NN, Ahuja KK, Morris N, Shaw RW: The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos. Fertil Steril 1990;53:1087-1090.
5. Anderson K, Haxton M, Banham S, Black WP: Unilateral pleural effusion as the presenting feature of ovarian hyperstimulation syndrome. Scott Med J 1988;33:338-339.
6. Araujo E, Bernardini L, Frederick JL, Asch RH, Balmaceda JP: Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal phase support In assisted reproduction. J Assist Reprod Genet 1994;11:74-78.
7. Asch RH, Ivery G, Goldsman M, Frederick JL, Stone SC, Balmaceda JP: The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum Reprod 1993;8: 1015-1020.
8. Asch RH, Li HP, Balmaceda JP, Weckstein LN, Stone SC: Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod 1991;6:1395-1399.
9. Aurousseau MH, Samana MM, Belhassen A, Herve F, Hugues JN: Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum Reprod 1995;10:94-97.
10. Ayhan A, Tuncer ZS, Aksu AT: Ovarian hyperstimulation syndrome associated with spontaneous pregnancy. Hum Reprod 1996;11:1600-1601.
11. Ayhan A, Uman B, Gurgan T, Tuncer ZS, Deren O: Thrombosis of the internal jugular vein associated with severe ovarian hyperstimulation syndrome. Aust N Z J Obstet Gynaecol 1993;33:436-437.
12. Bachmeyer C, Grateau G, Gruel D, Sereni D: Thrombosis of the internal jugular vein in ovarian hyperstimulation syndrome. Rev Med Interne 1994;15:52-54.
13. Balasch J, Arroyo V, Carmona F, Llach J, Jimenez W, Pare JC, Vanrell JA: Severe ovarian hyperstimulation syndrome: role of peripheral vasodilatation. Fertil Steril 1991;56:1077-1083.
14. Balasch J, Carmona F, Llach J, Arroyo V, Jove I, Vanrell JA: Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. Hum Reprod 1990;5:348-351.
15. Ben Hur H, Dgani R, Lancet M, Katz Z, Nissim F, Rosenman D: Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. Acta Obstet Gynecol Scand 1986;65:813-814.
16. Ben-Rafael Z, Orvieto R: The role of interleukin-2 in ovarian hyperstimulation syndrome. IXth world congress on human reproduction. Abstract Book, 1996, abstract 271.
17. Benifla JL, Conard J, Naouri M, Darai E, Bascou V, Neuraz A, Deval B, Guglielimina JN, Crequat J, Madlenat P: Ovarian hyperstimulation syndrome and thrombosis. Apropos of a case of thrombosis of the internal jugular vein. J Gynecol Obstet Biol Reprod Paris 1994;23:778-783.
18. Blankstein J, Shalev J, Saadon T, Kukia EE, Rabinovici J, pariente C, Lunenfeld B, Serr DM, Mashiach S: Ovarian hyperstimulation syndrome prediction by number and size of preovulatory ovarian follicles. Fertil Steril 1987;47:597-602.
19. Bornstein R, Ashkenazy M, Rosenman D, et al: Ovarian hyperstimulation syndrome after different treatment schedules. Int J Fertil 1981;26:279.
20. Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS: Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995;102:767-772.
21. Casper RF: Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome? Hum Reprod 1996;11:1144-1146.
22. Choktanasiri W, Rojanasakul A: Acute arterial thrombosis after gamete intrafallopian transfer: a case report. J Assist Reprod Genet 1995;12:335-337.
23. Chow KK, Choo HT: Ovarian hyperstimulation syndrome with clomiphene citrate. Case report. Br J Obstet Gynaecol 1984;91:1051-1052.
24. Cornwalls CM, Skinner SL, Nayudu PL, Lopata A, Thatcher RL, Yeung SP, Whitworth JA: Follicular fluid renin concentration and IVF outcome. Hum Reprod 1990;5:413-417.
25. Crouet H, Herlicoviez M, Rouffet P, Mandard JC, Levy G: Luteinized cystic hyperplasia of the ovaries in normal pregnancy. Diagnostic and nosological problems. J Gynecol Obstet Biol Reprod (Paris) 1985;14:613-618.
26. Dale PO, Tanbo T, Abyholm T: In vitro fertilization in infertile women with the polycystic ovarian syndrome. Hum Reprod 1991;6:238-241.
27. Dale PO, Tanbo T, Henriksen T, Magnus O, Abyholm T: Gonadotropin therapy of female infertility. Acta Endocrinol Copenh 1989;120:395-399.
28. Daniel Y, Yaron Y, Oren M, Peyser MR, Lessing JB: Ovarian hyperstimulation syndrome manifests as acute unilateral hydrothorax. Hum Reprod 1995;10:1684-1685.
29. Danninger B, Brunner M, Obruca A, Feichtinger W: Prediction of ovarian hyperstimulation syndrome of baseline ovarian volume prior to stimulation. Hum Reprod 1996;11:1597-1599.
30. Delbaere A, Berman PJ, Grvy-Decoster C, Staroukine M, Englert Y: Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Fertil Steril 1994;62:731-737.
31. Delvigne A, Demoulin A, Smitz J, Donnez J, Koninckx P, Dhont M, Englert Y, Delbeke L, Darcis L, Gordts S, et al: The ovarian hyperstimulation syndrome in in vitro fertilization: a Belgian multricentric study. I Clinical and biological features. Hum Reprod 1993;8:1353-1360.
32. Derkx FH, Schalekamp MA: Human prorenin: pathophysiology and clinical implication. Clin Exp Hypertens 1988;10:1213-1225.
33. Dumont M, Combet A, Domechini Y: Thrombose artérielle cérébrale à la suite d'une hyperstimulation ovarienne: grossesse sextuple, avortement thérapeutique. Nouv Presse Med 1980;9:3628-3631.
34. Ellis JD, Williamson JG: Factors influencing the pregnancy and complication rates with human menopausal gonadotrophin therapy. Br J Obstet Gynaecol 1975;82:52-57.
35. Emperaire JC, Verdaguer S, Meulet-Girard Y, Audebert AJ: Intra-uterine insemination with activated sperm. Results of conception compared in the various types of infertility in spouses. J Gynecol Obstet Biol Reprod (Paris) 1988;17:387-395.
36. Fakih H, Bello S: Ovarian cyst aspiration: a therapeutic approach to ovarian hyperstimulation syndrome. Fertil Steril 1992;58:829-832.
37. Ferraretti AP, Gianaroli L, Diotallevi L, Festi C, Trounson A: Dopamine treatment for severe ovarian hyperstimulation syndrome. Hum Reprod 1992;7:180-183.
38. Forman RG, Frydman R, Egan D, Ross C, Barlow DH: Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilisation: a European series and a proposal for prevention. Fertil Steril 1990;53:502-509.
39. Fournet N, Surrey E, Kerin J: Internal jugular vein thrombosis after ovulation induction with gonadotropins. Fertil Steril 1991;56:354-356.
40. Friedlander MA, Loret-de-Mola JR, Goldfarb JM: Elevated levels of interleukin 6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril 1993;60:826-833.
41. Fukaya T, Chida S, Terada Y, Funayama Y, Yajima A: Treatment of severe ovarian hyperstimulation syndrome by ultrafiltration and reinfusion of ascitiy fluid. Fertil Steril 1993;61:561-564.
42. Gergely RZ, Paldi E, Erlik Y, Makler A: Treatment of ovarian hyperstimulation syndrome by antihistamine. Obste Gynecol 19976;47:83-85.
43. Germond M, Wirthner D, Thorin D, Ruchat P, Essinger A, De Grandi P: Aorta-subclavian thromboembolism: a rare complication associated with moderate ovarian hyperstimulation syndrome. Hum Reprod 1996;11:1173-1176.
44. Golan A, Ron-El R, Herman A: Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989;44:430-440.
45. Goldschmit R, Elchalal U, Zalel Y, Barash A, Borenstein R, Insler V: Hypovolemic shock as a presenting sign of severe ovarian hyperstimulation syndrome following in vitro fertilization and embryo transfer (IVF-ET). J Assist Reprod Genet 1993;10:480-482.
46. Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Ash RH: Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril 1995;63:268-272.
47. Goshen R, Lavy Y, Lochner-Celnikier H, Milwidsky A: Third trimester torsion of persistent ovarian cyst following ovarian hyperstimulation - an unsusual cause of preterm labor. Gynecol Obstet Invest 1992;33:244-245.
48. Holtz G, Kling OR, Miller DD, Wilson DA: Ovarian hyperstimulation syndrome caused by clomiphene citrate. South Med J 1982;75:368-369.
49. Hsieh MJ, Sao TC, Cheng PJ: Ovarian hyperstimulation syndrome with minimal ascites and massive pleural effusion: report of a case. J formos Med Ass 1994;93:882-884.
50. Hulinsky I, Smith HC: External jugular vein thrombosis: a complication of the ovarian hyperstimulation syndrome. Med J Aus 1995;162:102-103.
51. Humbert G, Delaunay P, Leroy J, et al: Accident vasculaire cérébral au cours d'un traitement par les gonadotrophines. Nouv Presse Med 1973;2:28-30.
52. Hurwitz A, Krausz M, Eldar-Gebe T, Yagel S, Schenker JG, Palti Z, Laufer N: Production of 6-keto PGF1 alpha in hyperstimulated cycles: in vivo and in vitro studies. Int J Fertil 1991;36:252-256.
53. Hurwitz A, Milwidsky A, Yagel S, Adoni A: Early unwinding of torsion of an ovarian cyst as result of hyperstimulation syndrome. Fertil Steril 1983;40:393-394.
54. Inbar OJ, Levran D, Mashiach S, Dor J: Ischemic stroke due to induction of ovulation with clomiphene citrate and menotropins without evidence of ovarian hyperstimulation syndrome. Fertil Steril 1994;62:1075-1076.
55. Itskovitz J, Boldes R, Levron J, et al: Induction of preovulatory luteinizig hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 1991;56:213-220.
56. Itskovitz J, Boldes R, Varlev A, et al: The indcution of LH surge and oocyte maturization by GnRH analogue (buserelin) in women undergoing ovarian stimulation for in vitro fertilization. Gynecol Endocrinol 1988;2 (suppl 2): 165.
57. Itzkovitz-Eldor J, Levron J, Kol S: Use of gondotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndrome. Clin Obstet Gynecol 1993;36:701-710.
58. Iwabe T, Harada T, Tuzaki T, Terakawa N: Laparoscopic unwinding of adnexal torsion caused by ovarian hyperstimulation. Hum Reprod 1994;9:2350-2352.
59. Jewelewicz R, Vande Wiele RL: Acute hydrothorax as the only symptom of ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1975;121:1121.
60. Kaaja R, Siegberg R, Titinen A, Koskimies A: Severe ovarian hyperstimulation syndrome and deep venous thrombosis. Lancet 1989;2:1043.
61. Kermode AG, Churchyard A, Carroll WM: Stroke complicating severe ovarian hyperstimulation syndrome. Aust N Z J Med 1993;23:219-220.
62. Kessler R, Vandevenne A, Fraisse P, Gangi A, Lecat G, Roegel E: Pleurisy in ovarian hyperstimulation syndrome. Apropos of a case. Rev Mal Respir 1990;7:599-601.
63. Kligman I, Noyes N, Venadiva C.A, Rosenwaks Z: Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 1995;63:673-676.
64. Knox GE, Dowd AJ, Spiesel SA, Hong R: Antihistamine blockade of the ovarian hyperstimulation syndrome. II. Possible role of antigen-antibody complexes in the pathogenesis of the syndrome. Fertil Steril 1975;26:418-421.
65. Lanzone A, Fulghesu A.M, Villa P, Guida C, Guido M, Nicoletti MC, Caruso A, Mancuso S: Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian diasease gonadotropin hyperstimulated cycles. Fertil Steril 1994;62:35-41.
66. Leis D, Richter K, Schmid K: Spontaneous hyperstimulation of the ovaries with luteal cysts and ascites during a twin pregnancy - extreme case of the syndrome of painfull early pregnancy. Geburtshilfe Frauenheilk 1978;38:1085-1087.
67. Levin MF, Kaplan BR, Hutton LC: Thoracic manifestations of ovarian hyperstimulation syndrome. Can Ass Radiol J 1995;46:23-26.
68. Lewit N, Kol S, Manor D, Itskovitz-Eldor J: The use of GnRH analogs for induction of the preovulatory gondotropin surge in assisted reproduction and prevention of the ovarian hyperstimulation syndrome. Gynecol Endocrinol 1995; (suppl 4): 13-17.
69. Lindner C, Braendle W, Kohler S, Bettendorf G: Vermehrte Häufigkeit des ovariellen Überstimulationssyndromes nach GnRH-Analoga/HMG Therapie. Geburtshilfe Frauenheilk 1989;49:337-344.
70. Lipltz S, Ben-Rafael Z, Elder D, Shalev J, Mashiach S: Quintuplet pregnancy and third degree ovarian hyperstimulation despite withholding human chorionic gonadotropin. Hum Reprod 1991;6:1478-1479.
71. Loret de Mola JR, Flores JP, Baumgardner GP, Goldfarb JM: Elevated interleukin 6 levels in the ovarian hyperstimulation syndrome: ovarian immunohistochemical localization of interleukin-6 signal. Obstet Gynecol 1996;87:581-587.
72. Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV jr: Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994;9:792-799.
73. Mac Dougall MJ, Tan SI, Jacobs HS: In vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992;7:597-600.
74. Manaka C, Akabori A, Araki S, Tamada T: Changes in coagulability and fibrinolytic activity in the patients with ovarian hyperstimulation syndrome. Nippon Sanka Fujinka Gakkai Zasshi 1991;32: 1653-1659.
75. Marsepoil T, Cordesse A, Varguy P, Dauptain G, Levesque P: Hepatic involvement in the course of ovarian hyperstimulation syndrome. Rev Fr Gynecol Obstet 1992;87:148-149.
76. Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael Z: Adnexial torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril 1990;53:76-80.
77. McClure N, Leya J, Radwanska E, Rawlins R, Haning RV jr: Luteal phase support and severe ovarian hyperstimulation syndrome. Hum Reprod 1992;7:758-764.
78. Mills MS, Eddowes HA, Fox R, Wardle G: Subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome. Hum Reprod 1992;7:778-783.
79. Morris RS, Miller C, Jacobs L, Miller K: Conservative management of ovarian hyperstimulation syndrome. J Reprod Med 1995;40:711-714.
80. Morris RS, Paulson RJ: Ovarian derived prorenin-angiotensin cascade in human reproduction. Fertil Steril 1994;62:1105-1114.
81. Morris RS, Wong IL, Kirkma E, Gentschein E, Paulson RJ: Inhibition of ovarian derived prorenin to angioensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum Reprod 1995;10:1355-1358.
82. Mozes M, Bogokowsky H, Antebi E: Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet 1965; 11:1213-1215.
83. Mukherjee T, Copperman AB, Sandler B, Bustillo M, Grunfeld L: Severe ovarian hyperstimulation despite prophylactic albumin at the time of oocyte retrieval for in-vitro fertilization and embryo transfer. Fertil Steril 1995;63:641-643.
84. Murakawa H, Utsumi T, Hasegawa I, Tanaka K, Fujimori R: Low-dose dopamine treatment for severe ovarian hyperstimulation syndrome. Nippon Sanka Fujinka Gakkai Zasshi 1993;45:1147-1150.
85. Navot D, Bergh PA, Laufer N: Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-261.
86. Navot D, Margalioth EJ, Laufer N, Birkenfeld A, Relou A, Rosler A, Schenker JG: Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 1987;48:57-61.
87. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ: Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1988;159:210.
88. Neau JP, Marechaud M, Guitton P, et al: Occlusion de l'artère cérébrale moyenne lors d'une induction de l'ovulation par les gonadotrophines. Rev Neurol 1989;145:859-861.
89. Neulen J, Dvorak HF, Yeo KT, Breckwoldt M: VEGF/VPF - gene expression and production by human granulosa cells: clinical implication. IXth world congress on human reproduction. Abstract book 1996, abstract 287.
90. Ng E, Leader A, Claman P, Domingo M, Spence JE: Intravenous albumin does not prevent the development of severe ovarian hyperstimulation in an in-vitro-fertilization program. Hum Reprod 1995;10:807-810.
91. Ong AC, Eisen V, Rennie DP, Hombrg R, Lachelin GC, Jacobs HS, Slater JD: The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin. Clin Endocrinol Oxf 1991;34:43-49.
92. Orvieto R, Voliovitch I, Fishman P, Ben Rafael Z: Interluekin-2 and ovarian hyperstimulation syndrome: a pilot study. Hum Reprod 11995;0:24-27.
93. Padila SL, Zamaria S, Baramki TA, Garcia JE: Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise. Fertil Steril 1990;53:365-367.
94. Philips LL, gladstone W, van de Wiele R: studies of the coagulation and fibronlytic systems in hyperstimulation syndrome after the administration of human gonadotropin. J Reprod Med 1975;14:138-143.
95. Pride SM, Ho Yuen B, Moon YS: Clinical, endocrinologic, and intraovarian prostaglandin F responses to H1 receptor blockade in the ovarin hyperstimulation syndrome studies in the rabbit model. Am J Obstet Gynecol 1984;148:670-674.
96. Pryor RA, Wiczyk HP, O'Shea DL: Adnexal infarction after conservative surgical management of torsion of hyperstimulated ovary. Fertil Steril 1995;63:1344-1346.
97. Quartero HW, Dixon JE, Westwood O, Hicks B, Chapman MG: Ovulation induction in polycystic ovarian disease by pure FSH (Metrodin). A comparison between chronic low dose pulsatile administration and i.m. injections. Hum Reprod 1989;4:247-249.
98. Rabau E, David A, Serr DM, Mashiach S, Lunenfeld B: Human menopausal gonadotropins for anovulation and sterility. Am J Obstet Gynecol 1967;98:92-98.
99. Rizk B, Aboulghar M: Modern management of ovarian hyperstimulation syndrome. Hum Reprod 1991;6:1082-1087.
100. Rizk B, Meagher S, Fischer A-M: Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum Reprod 1990;5:697-698.
101. Robertson D, Selleck K, Suikkari AM, Hurley V, Moohan J, Healy D: Urinary vascular endothelial growth factor concentration in women undergoing gonadotropin treatment. Hum Reprod 1995;10:2478-2482.
102. Roland M: Problems of ovulation Induction with clomiphene citrate with report of a case of ovarian hyperstimulation. Obstet Gynecol 1975;35:55-62.
103. Rosen GF, Lew MW: Severe ovarian hyperstimulation syndrome in a spontaneous singleton pregnancy. Am J Obstet Gynecol 1991;165:1312-1313.
104. Rosenberg ME, Mckenzie JK, Mckenze IM, Junaid A, Tagatz GE: Increased ascitic fluid prorenin in the ovarian hyperstimulation syndrome. Am J Kidney Dis 1994;23:427-429.
105. Rotmensch S, Scommegna A: Spontaneous ovarian hyperstimulation syndrome associated with hypothyroidism. Am J Obstet Gynecol 1989;160;1220-1222.
106. Ryley NG, Forman R, Brlow D, Fleming KA, Trowell JM: Liver abnormality in ovarian hyperstimulation syndrome. Hum Reprod 1990;5:938-943.
107. Segal S, Casper RF: Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertil Steril 1992;57:1254-1258.
108. Shalev E, Giladi Y, Matilsky M, Ben-Amin M: Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: a prospective study. Hum Reprod 1995;10:1373-1376.
109. Shalev E, Peleg D: Laparoscopic treatment of adnexial torsion. Surg Gynecol Obstet 1993;176:448-450.
110. Shand KL, Haines CJ, Loong EP: Severe ovarian hyperstimulation syndrome with minimal ovarian enlargement: a case report. Asia Oceania J Obstet Gynaecol 1992;18:219-223.
111. Schenker JG, Ezra Y: Complications of assisted reproductive techniques. Fertil Steril 1994;61:411-422.
112. Sher G, Salem R, Feinman M, Dodge S, Zouves C, Knutzen V: Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol 1993;81:1009-1011.
113. Shoham Z, Weissman A, Barash A, Borenstein R, Schachter M, Insler V: Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective randomized placebo-controlled study. Fertil Steril 1994;62:137-142.
114. Shristav P, Nadkarni P, Craft I: Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity. Hum Reprod 1994;9:812-814.
115. Shweiki D, Itin A, Gitay-Goren H, Keshet E: Patterns of expresson of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993;91:2235-2243.
116. Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC: Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod 1990;5:933-937.
117. Spendiani G, Mazzarella V, Tozzo C, Elli M, Casciani CU: Autologous protein reinfusion in severe ovary hyperstimulation syndrome. J Am Coll Surg 1994;179:25-28.
118. Sueldo CE, Price HM, Bachenberg K, Steinleitner A, Gitlin N, Swanson J: Liver dysfunction in ovarian hyperstimulation syndrome. A case report. J Reprod Med 1988;33:387-390.
119. Tal J, Haddad S, Gordon N, Timor-Tritsch I: Heterotopic pregnancy after ovulation induction and assisted reproductive technologies: a literature review from 1971 to 1993. Fertil Steril 1996;66:1-12.
120. Tan SL, Balen A, El Hussein E, Campbell S, Jacobs HS: The administration of glucocotricoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: a prospective randomized study. Fertil Steril 1992;58:378-383.
121. Tekay A, Martikainen H, Jouppila P: Doppler parameters of the ovarian and uterine blood circulation in ovarian hyperstimulation syndrome. Ultrasound Obstct Gynecol 1995;6:50-53.
122. Tiitinen A, Husa LM, Tulppala M, Simberg N, Seppala M: The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995;102:326-329.
123. Tspoulis AD, Zourlas PA, Comnios AC: Observation on 320 infertile patients treated with human gonadotropins (human menopausal gonadotropin/human chorionic gonadotropin). Fertil Steril 1978;29:492-495.
124. Tulandi T, McInnes RA, Arronet GH: Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin. Int J Fert 1984;29:113-117.
125. Ugoscal G, Szollosi J, Godo G: Simultaneous occurence of bilateral extrauterine pregnancy and ovarian hyperstimulaton syndrome following arterificial heterologous insemination. Orv Hetil 1990;131:363-365.
126. Van der Merwe JP, Michell WL, Kruger TF: Severe ovarian hyperstimulation after follicular aspiration. S Afr Med J 1988;73:426-427.
127. Vrtovec HM, Tomazevic T: Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration. J Reprod Med 1995;40:37-40.
128. Wada I, Matson PL, Macnamae MC, Brinsden PR, Lieberman BA: High ovarian response in yoruba african women during ovulation induction for assisted conception. Hum Reprod 1994;9:1077-1080.
129. Wada I, Matson PL, Troup SA, Hughes S, Buck P, Lieberman BA: Outcome of treatment subsequent to the elective cryopreservation of all embryos from women at risk of the ovarian hyperstimulation syndrome. Hum Reprod 1992;7:962-966.
130. Wada I, Matson PL, Troup SA, Morroll DR, Hunt L, Lieberman BA: Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition? Br J Obstet Gynaecol 1993;100:265-269.
131. Waterstone JJ, Summers BA, Hoskins MC, Berry J, Parsons JH: Ovarian hyperstimulation syndrome and deep cerebral venous thrombosis. Br J Obstet Gynecol 1992;99:439-440.
132. Willms AB, Schlund JF, Meyer WR: Endovaginal doppler ultrasound in ovarian torsion: a case series. Ultrasound Obstet Gynecol 1995;5:129-132.
133. Yarali H, Fleige-Zahrada BG, Yuen BH, McComb PF: The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary. Fertil Steril 1993;59:657-661.
134. Younis JS, Zeevi D, Rabinowitz R, Laufer S, Schenker JG: Transient liver function tests abnormalities in ovarian hyperstimulation syndrome. Fertil Steril 1988;50:176-178.
135. Zalel Y, Katz Z, Caspi B, Ben Hur H, Dgani R, Insler V: Spontaneous ovarian hyperstimulation syndrome concomitant with spontaneous pregnancy in a woman with polycystic ovary disease. Am J Obstet Gynecol 1992;167:122-124.
136. WHO: Agents stimulating gonadal function in human. World Health Organ Tech Rep Ser p. 514.